{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T16:44:46Z","timestamp":1775321086094,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Research Ward Excellence Program, BRWEP","award":["BRWEP2024W042180111"],"award-info":[{"award-number":["BRWEP2024W042180111"]}]},{"name":"Beijing Research Ward Excellence Program, BRWEP","award":["BRWEP2024W042180111"],"award-info":[{"award-number":["BRWEP2024W042180111"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00277-025-06424-9","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T04:20:30Z","timestamp":1748578830000},"page":"3411-3422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinicopathological features and prognostic factors of AIDS-related lymphoma: a retrospective single-center study in China"],"prefix":"10.1007","volume":"104","author":[{"given":"Ying","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhujun","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingjia","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caiping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"6424_CR1","unstructured":"UNAIDS. The urgency of now: AIDS at a crossroads\u20142024 global AIDS update (2024) Available from: https:\/\/www.unaids.org\/en\/resources\/documents\/2024\/global-aids-update-2024"},{"key":"6424_CR2","doi-asserted-by":"crossref","unstructured":"Jacobson CA, Abramson JS. HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cART. Adv Hematol 2012; 2012:507257.","DOI":"10.1155\/2012\/507257"},{"issue":"9119","key":"6424_CR3","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/S0140-6736(97)09028-4","volume":"351","author":"JJ Goedert","year":"1998","unstructured":"Goedert JJ, Cot\u00e9 TR, Virgo P et al (1998) Spectrum of AIDS-associated malignant disorders. Lancet 351(9119):1833\u20131839","journal-title":"Lancet"},{"key":"6424_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1750-9378-10-4","volume":"10","author":"JL Castilho","year":"2015","unstructured":"Castilho JL, Luz PM, Shepherd BE et al (2015) HIV and cancer: a comparative retrospective study of Brazilian and U.S. Clinical cohorts. Infect Agent Cancer 10:4","journal-title":"Infect Agent Cancer"},{"issue":"3","key":"6424_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1158\/1055-9965.EPI-16-0595","volume":"26","author":"X Han","year":"2017","unstructured":"Han X, Jemal A, Hulland E et al (2017) HIV infection and survival of lymphoma patients in the era of highly active antiretroviral therapy. Cancer Epidemiol Biomarkers Prev 26(3):303\u2013311","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"6424_CR6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/cncr.20354","volume":"101","author":"F Bonnet","year":"2004","unstructured":"Bonnet F, Lewden C, May T et al (2004) Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer 101(2):317\u2013324","journal-title":"Cancer"},{"issue":"5","key":"6424_CR7","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/QAI.0b013e31817efb54","volume":"48","author":"C Lewden","year":"2008","unstructured":"Lewden C, May T, Rosenthal E et al (2008) Changes in causes of death among adults infected by HIV between 2000 and 2005: the Mortalit\u00e9 2000 and 2005 surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr 48(5):590\u2013598","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"6424_CR8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3109\/10428194.2015.1055483","volume":"57","author":"DJ Riedel","year":"2016","unstructured":"Riedel DJ, Rositch AF, Redfield RR et al (2016) HIV-associated lymphoma sub-type distribution, immunophenotypes and survival in an urban clinic population. Leuk Lymphoma 57(2):306\u2013312","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"6424_CR9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/01.cco.0000432525.70099.a4","volume":"25","author":"E Cesarman","year":"2013","unstructured":"Cesarman E (2013) Pathology of lymphoma in HIV. Curr Opin Oncol 25(5):487\u2013494","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"6424_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1086\/599313","volume":"200","author":"A Zoufaly","year":"2009","unstructured":"Zoufaly A, Stellbrink HJ, Heiden MA et al (2009) Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphoma. J Infect Dis 200(1):79\u201387","journal-title":"J Infect Dis"},{"issue":"1","key":"6424_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/01.qai.0000371677.48743.8d","volume":"54","author":"EA Engels","year":"2010","unstructured":"Engels EA, Pfeiffer RM, Landgren O et al (2010) Immunologic and virologic predictors of AIDS-related non-hodgkin lymphoma in the highly active antiretroviral therapy era. J Acquir Immune Defic Syndr 54(1):78\u201384","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"6424_CR12","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/S1470-2045(09)70282-7","volume":"10","author":"M Guiguet","year":"2009","unstructured":"Guiguet M, Bou\u00e9 F, Cadranel J et al (2009) Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol 10(12):1152\u20131159","journal-title":"Lancet Oncol"},{"issue":"16","key":"6424_CR13","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1002\/cncr.32158","volume":"125","author":"AE Coghill","year":"2019","unstructured":"Coghill AE, Han X, Suneja G et al (2019) Advanced stage at diagnosis and elevated mortality among US patients with cancer infected with HIV in the National Cancer data base. Cancer 125(16):2868\u20132876","journal-title":"Cancer"},{"issue":"8","key":"6424_CR14","doi-asserted-by":"publisher","first-page":"986","DOI":"10.6004\/jnccn.2018.0066","volume":"16","author":"E Reid","year":"2018","unstructured":"Reid E, Suneja G, Ambinder RF et al (2018) Cancer in people living with HIV, version 1.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 16(8):986\u20131017","journal-title":"J Natl Compr Canc Netw"},{"issue":"33","key":"6424_CR15","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.1200\/JCO.2017.73.7338","volume":"35","author":"TS Uldrick","year":"2017","unstructured":"Uldrick TS, Ison G, Rudek MA et al (2017) Modernizing clinical trial eligibility criteria: recommendations of the American society of clinical Oncology-Friends of Cancer research HIV working group. J Clin Oncol 35(33):3774\u20133780","journal-title":"J Clin Oncol"},{"issue":"7","key":"6424_CR16","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I et al (2022) The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 36(7):1720\u20131748","journal-title":"Leukemia"},{"issue":"Suppl 2","key":"6424_CR17","first-page":"1","volume":"15","author":"M Bower","year":"2014","unstructured":"Bower M, Palfreeman A, Alfa-Wali M et al (2014) British HIV association guidelines for HIV-associated malignancies 2014. HIV Med 15(Suppl 2):1\u201392","journal-title":"HIV Med"},{"issue":"11","key":"6424_CR18","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","volume":"7","author":"TA Lister","year":"1989","unstructured":"Lister TA, Crowther D, Sutcliffe SB et al (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2019s disease: Cotswolds meeting. J Clin Oncol 7(11):1630\u20131636","journal-title":"J Clin Oncol"},{"issue":"4","key":"6424_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier B, Lepage E, Briere J et al (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346(4):235\u2013242","journal-title":"N Engl J Med"},{"issue":"15","key":"6424_CR20","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1182\/blood-2009-08-231613","volume":"115","author":"JA Sparano","year":"2010","unstructured":"Sparano JA, Lee JY, Kaplan LD et al (2010) Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma. Blood 115(15):3008\u20133016","journal-title":"Blood"},{"issue":"8","key":"6424_CR21","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1200\/JCO.1999.17.8.2461","volume":"17","author":"DA Thomas","year":"1999","unstructured":"Thomas DA, Cortes J, O\u2019Brien S et al (1999) Hyper-CVAD program in Burkitt\u2019s-type adult acute lymphoblastic leukemia. J Clin Oncol 17(8):2461\u20132470","journal-title":"J Clin Oncol"},{"key":"6424_CR22","doi-asserted-by":"publisher","first-page":"102480","DOI":"10.1016\/j.eclinm.2024.102480","volume":"69","author":"M Mponda","year":"2024","unstructured":"Mponda M, Kudowa E, Craven DM et al (2024) Safety, efficacy, and affordability of ABVD for hodgkin lymphoma in Malawi: a prospective cohort study. EClinicalMedicine 69:102480","journal-title":"EClinicalMedicine"},{"key":"6424_CR23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41408-022-00630-8","volume":"12","author":"A Berhan","year":"2022","unstructured":"Berhan A, Bayleyegn B, Getaneh Z (2022) HIV\/AIDS associated lymphoma: review. Blood Lymphat Cancer 12:31\u201345","journal-title":"Blood Lymphat Cancer"},{"issue":"11","key":"6424_CR24","doi-asserted-by":"publisher","first-page":"e495","DOI":"10.1016\/S2352-3018(17)30125-X","volume":"4","author":"RU Hern\u00e1ndez-Ram\u00edrez","year":"2017","unstructured":"Hern\u00e1ndez-Ram\u00edrez RU, Shiels MS, Dubrow R et al (2017) Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study. Lancet HIV 4(11):e495\u2013e504","journal-title":"Lancet HIV"},{"issue":"2","key":"6424_CR25","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10238-021-00683-2","volume":"21","author":"S Jain","year":"2021","unstructured":"Jain S, Lone MR, Goswami A et al (2021) Lymphoma subtypes in India: a tertiary care center review. Clin Exp Med 21(2):315\u2013321","journal-title":"Clin Exp Med"},{"issue":"11","key":"6424_CR26","doi-asserted-by":"publisher","first-page":"5843","DOI":"10.1002\/cam4.1805","volume":"7","author":"R Muto","year":"2018","unstructured":"Muto R, Miyoshi H, Sato K et al (2018) Epidemiology and secular trends of malignant lymphoma in Japan: analysis of 9426 cases according to the world health organization classification. Cancer Med 7(11):5843\u20135858","journal-title":"Cancer Med"},{"issue":"18","key":"6424_CR27","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1097\/QAD.0000000000001652","volume":"31","author":"C Besson","year":"2017","unstructured":"Besson C, Lancar R, Prevot S et al (2017) Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era. AIDS 31(18):2493\u20132501","journal-title":"AIDS"},{"issue":"16","key":"6424_CR28","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1093\/jnci\/djt158","volume":"105","author":"S Gopal","year":"2013","unstructured":"Gopal S, Patel MR, Yanik EL et al (2013) Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era. J Natl Cancer Inst 105(16):1221\u20131229","journal-title":"J Natl Cancer Inst"},{"issue":"25","key":"6424_CR29","doi-asserted-by":"publisher","first-page":"5600","DOI":"10.1182\/blood-2010-03-275917","volume":"116","author":"M Guech-Ongey","year":"2010","unstructured":"Guech-Ongey M, Simard EP, Anderson WF et al (2010) AIDS-related Burkitt lymphoma in the united States: what do age and CD4 lymphocyte patterns tell Us about etiology and\/or biology? Blood 116(25):5600\u20135604","journal-title":"Blood"},{"key":"6424_CR30","doi-asserted-by":"crossref","unstructured":"Hjalgrim H, Friborg J, Melbye M. The epidemiology of EBV and its association with malignant disease. In: Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Arvin A, Campadelli-Fiume G, Mocarski E, et al. (editors). Cambridge: Cambridge University Press Copyright \u00a9 Cambridge University Press 2007.; 2007.","DOI":"10.1017\/CBO9780511545313.054"},{"issue":"12","key":"6424_CR31","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1136\/jcp.2007.051953","volume":"60","author":"KL Grogg","year":"2007","unstructured":"Grogg KL, Miller RF, Dogan A (2007) HIV infection and lymphoma. J Clin Pathol 60(12):1365\u20131372","journal-title":"J Clin Pathol"},{"issue":"4","key":"6424_CR32","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/QAD.0000000000000071","volume":"28","author":"PG Rubinstein","year":"2014","unstructured":"Rubinstein PG, Aboulafia DM, Zloza A (2014) Malignancies in HIV\/AIDS: from epidemiology to therapeutic challenges. Aids 28(4):453\u2013465","journal-title":"Aids"},{"issue":"5","key":"6424_CR33","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/cncr.25547","volume":"117","author":"EP Simard","year":"2011","unstructured":"Simard EP, Pfeiffer RM, Engels EA (2011) Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the united States. Cancer 117(5):1089\u20131096","journal-title":"Cancer"},{"issue":"4","key":"6424_CR34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1053\/j.seminhematol.2022.11.002","volume":"59","author":"K Lurain","year":"2022","unstructured":"Lurain K, Ramaswami R, Yarchoan R (2022) The role of viruses in HIV-associated lymphomas. Semin Hematol 59(4):183\u2013191","journal-title":"Semin Hematol"},{"key":"6424_CR35","doi-asserted-by":"crossref","unstructured":"Chong Y, Kim TE, Cho U, et al. Comparison of Ki-67 Labeling Index Patterns of Diffuse Large B-Cell Lymphomas and Burkitt Lymphomas Using Image Analysis: A Multicenter Study. Diagnostics (Basel) 2021; 11(2).","DOI":"10.3390\/diagnostics11020343"},{"issue":"10","key":"6424_CR36","first-page":"e72190","volume":"16","author":"NJ Harlendea","year":"2024","unstructured":"Harlendea NJ, Harlendo K (2024) Ki-67 as a marker to differentiate Burkitt lymphoma and diffuse large B-cell lymphoma: A literature review. Cureus 16(10):e72190","journal-title":"Cureus"},{"issue":"3","key":"6424_CR37","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/PAS.0000000000000365","volume":"39","author":"KM Chisholm","year":"2015","unstructured":"Chisholm KM, Bangs CD, Bacchi CE et al (2015) Expression profiles of MYC protein and MYC gene rearrangement in lymphomas. Am J Surg Pathol 39(3):294\u2013303","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"6424_CR38","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/cjp2.223","volume":"7","author":"A Bouroumeau","year":"2021","unstructured":"Bouroumeau A, Bussot L, Bonnefoix T et al (2021) c-MYC and p53 expression highlight starry-sky pattern as a favourable prognostic feature in R-CHOP-treated diffuse large B-cell lymphoma. J Pathol Clin Res 7(6):604\u2013615","journal-title":"J Pathol Clin Res"},{"issue":"1","key":"6424_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1182\/blood-2017-06-740944","volume":"131","author":"N van de Donk","year":"2018","unstructured":"van de Donk N, Richardson PG, Malavasi F (2018) CD38 antibodies in multiple myeloma: back to the future. Blood 131(1):13\u201329","journal-title":"Blood"},{"key":"6424_CR40","doi-asserted-by":"crossref","unstructured":"Calabretta E, Carlo-Stella C. The Many Facets of CD38 in Lymphoma: From Tumor-Microenvironment Cell Interactions to Acquired Resistance to Immunotherapy. Cells 2020; 9(4).","DOI":"10.3390\/cells9040802"},{"issue":"9","key":"6424_CR41","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1097\/00002030-200006160-00004","volume":"14","author":"A Savarino","year":"2000","unstructured":"Savarino A, Bottarel F, Malavasi F et al (2000) Role of CD38 in HIV-1 infection: an epiphenomenon of T-cell activation or an active player in virus\/host interactions? AIDS 14(9):1079\u20131089","journal-title":"AIDS"},{"issue":"6","key":"6424_CR42","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1080\/10428194.2021.2023741","volume":"63","author":"TE Hybel","year":"2022","unstructured":"Hybel TE, Vase M, Lauridsen KL et al (2022) CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus. Leuk Lymphoma 63(6):1479\u20131483","journal-title":"Leuk Lymphoma"},{"issue":"13","key":"6424_CR43","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1056\/NEJMoa1506348","volume":"373","author":"HM Lokhorst","year":"2015","unstructured":"Lokhorst HM, Plesner T, Laubach JP et al (2015) Targeting CD38 with daratumumab monotherapy in multiple myeloma. N Engl J Med 373(13):1207\u20131219","journal-title":"N Engl J Med"},{"issue":"38","key":"6424_CR44","doi-asserted-by":"publisher","first-page":"6524","DOI":"10.1038\/sj.onc.1207843","volume":"23","author":"SG Fisher","year":"2004","unstructured":"Fisher SG, Fisher RI (2004) The epidemiology of non-Hodgkin\u2019s lymphoma. Oncogene 23(38):6524\u20136534","journal-title":"Oncogene"},{"issue":"11","key":"6424_CR45","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1182\/blood.2019003959","volume":"136","author":"JC Ramos","year":"2020","unstructured":"Ramos JC, Sparano JA, Chadburn A et al (2020) Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with Vorinostat (AMC-075 trial). Blood 136(11):1284\u20131297","journal-title":"Blood"},{"issue":"19","key":"6424_CR46","doi-asserted-by":"publisher","first-page":"7072","DOI":"10.1002\/cam4.3362","volume":"9","author":"S Habbous","year":"2020","unstructured":"Habbous S, Guo H, Beca J et al (2020) The effectiveness of rituximab and HIV on the survival of Ontario patients with diffuse large B-cell lymphoma. Cancer Med 9(19):7072\u20137082","journal-title":"Cancer Med"},{"issue":"5","key":"6424_CR47","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3324\/haematol.2017.180893","volume":"103","author":"P Schommers","year":"2018","unstructured":"Schommers P, Gillor D, Hentrich M et al (2018) Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort study. Haematologica 103(5):857\u2013864","journal-title":"Haematologica"},{"issue":"5","key":"6424_CR48","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/01.cco.0000172824.78318.b9","volume":"17","author":"M Spina","year":"2005","unstructured":"Spina M, Tirelli U (2005) Rituximab for HIV-associated lymphoma: weighing the benefits and risks. Curr Opin Oncol 17(5):462\u2013465","journal-title":"Curr Opin Oncol"},{"issue":"8","key":"6424_CR49","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1080\/14737140.2017.1344100","volume":"17","author":"VS Pokrovsky","year":"2017","unstructured":"Pokrovsky VS, Vinnikov D (2017) L-Asparaginase for newly diagnosed extra-nodal NK\/T-cell lymphoma: systematic review and meta-analysis. Expert Rev Anticancer Ther 17(8):759\u2013768","journal-title":"Expert Rev Anticancer Ther"},{"key":"6424_CR50","doi-asserted-by":"publisher","first-page":"1088685","DOI":"10.3389\/fimmu.2023.1088685","volume":"14","author":"Z Yan","year":"2023","unstructured":"Yan Z, Yao S, Wang Z et al (2023) Treatment of extranodal NK\/T-cell lymphoma: from past to future. Front Immunol 14:1088685","journal-title":"Front Immunol"},{"issue":"5","key":"6424_CR51","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1093\/annonc\/mdv036","volume":"26","author":"SK Barta","year":"2015","unstructured":"Barta SK, Samuel MS, Xue X et al (2015) Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma. Ann Oncol 26(5):958\u2013966","journal-title":"Ann Oncol"},{"issue":"1","key":"6424_CR52","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1038\/s41598-019-41869-9","volume":"9","author":"D Wu","year":"2019","unstructured":"Wu D, Chen C, Zhang M et al (2019) The clinical features and prognosis of 100 AIDS-related lymphoma cases. Sci Rep 9(1):5381","journal-title":"Sci Rep"},{"issue":"19","key":"6424_CR53","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1200\/JCO.2005.11.973","volume":"23","author":"ST Lim","year":"2005","unstructured":"Lim ST, Karim R, Nathwani BN et al (2005) AIDS-related Burkitt\u2019s lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy. J Clin Oncol 23(19):4430\u20134438","journal-title":"J Clin Oncol"},{"issue":"6","key":"6424_CR54","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/bjh.13221","volume":"168","author":"P Schommers","year":"2015","unstructured":"Schommers P, Hentrich M, Hoffmann C et al (2015) Survival of AIDS-related diffuse large B-cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV lymphoma cohort. Br J Haematol 168(6):806\u2013810","journal-title":"Br J Haematol"},{"issue":"12","key":"6424_CR55","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1002\/ajh.27470","volume":"99","author":"SM Ansell","year":"2024","unstructured":"Ansell SM (2024) Hodgkin lymphoma: 2025 update on diagnosis, risk-stratification, and management. Am J Hematol 99(12):2367\u20132378","journal-title":"Am J Hematol"},{"issue":"14","key":"6424_CR56","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1182\/blood-2011-08-373738","volume":"119","author":"K Dunleavy","year":"2012","unstructured":"Dunleavy K, Wilson WH (2012) How I treat HIV-associated lymphoma. Blood 119(14):3245\u20133255","journal-title":"Blood"},{"issue":"5","key":"6424_CR57","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1182\/blood-2004-12-4631","volume":"106","author":"C Hoffmann","year":"2005","unstructured":"Hoffmann C, Tiemann M, Schrader C et al (2005) AIDS-related B-cell lymphoma (ARL): correlation of prognosis with differentiation profiles assessed by immunophenotyping. Blood 106(5):1762\u20131769","journal-title":"Blood"},{"key":"6424_CR58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13027-017-0120-2","volume":"12","author":"Y Shen","year":"2017","unstructured":"Shen Y, Zhang R, Liu L et al (2017) Clinical and prognostic analysis of 78 patients with human immuno-deficiency virus associated non-Hodgkin\u2019s lymphoma in Chinese population. Infect Agent Cancer 12:7","journal-title":"Infect Agent Cancer"},{"issue":"10","key":"6424_CR59","doi-asserted-by":"publisher","first-page":"3832","DOI":"10.1182\/blood-2005-09-3600","volume":"107","author":"N Mounier","year":"2006","unstructured":"Mounier N, Spina M, Gabarre J et al (2006) AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy. Blood 107(10):3832\u20133840","journal-title":"Blood"},{"issue":"11","key":"6424_CR60","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.3324\/haematol.2014.111112","volume":"99","author":"SK Barta","year":"2014","unstructured":"Barta SK, Xue X, Wang D et al (2014) A new prognostic score for AIDS-related lymphomas in the rituximab-era. Haematologica 99(11):1731\u20131737","journal-title":"Haematologica"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06424-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06424-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06424-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T17:22:09Z","timestamp":1757179329000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06424-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["6424"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06424-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5998165\/v1","asserted-by":"object"}]},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Beijing Youan Hospital and performed in accordance with the 1975 Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}